Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Metadata
Title
Clinical Significance of Hyperexpression of Epidermal Growth Factor Receptors (EGFR and HER-2) in Esophageal Squamous Cell Carcinoma
Authors
V. V. Delektorskaya
G. Yu. Chemeris
P. V. Kononets
A. Yu. Grigorchuk
Publication date
01-08-2009
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 2/2009
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-009-0659-z

Other articles of this Issue 2/2009

Bulletin of Experimental Biology and Medicine 2/2009 Go to the issue

Ultralow Doses

Tenoten in the Therapy of Patients with Moderate Cognitive Impairment

Ultralow Doses

The Use of Tenoten Preparation in Complex Therapy of Hypomotoric Biliary Dyskinesia

Nanotechnology

Proliferation and Survival of Rat C6 Glioma Culture in the Presence of Implants Coated with Modified Carbon-Based Films

Ultralow Doses

Efficiency of Interferon Inductor Anaferon (Pediatric Formulation) in Prophylaxis of Acute Respiratory Infections in Sickly Children

Genetics

Norepinephrine Content in the Hypothalamus and Medulla Oblongata of ISIAH Rats is Regulated by Several Genetic Loci

General Pathology and Pathophysiology

Neurotransmitter Mechanisms of Morphine Withdrawal Syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits